PHI with climacteric disorders
How does this condition affect your private health insurance?
Klimakterische Störungen, commonly known as menopausal symptoms, encompass a range of physical and emotional changes experienced by women as they transition into menopause, typically between ages 45 and 55. These disturbances are primarily caused by declining estrogen levels, leading to symptoms such as hot flashes, night sweats, vaginal dryness, mood swings, sleep disturbances, and fatigue. While a natural physiological process, the severity and impact of these symptoms vary greatly among individuals, significantly affecting quality of life for many. Management often involves lifestyle adjustments, hormonal therapies, and non-hormonal treatments to alleviate discomfort and support overall well-being during this transitional phase.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Individual symptoms like hot flashes can last minutes, but the onset of menopausal symptoms can persist for several years, typically ranging from 4 to 8 years around the last menstrual period.
Duration of Illness (Lifetime)
Menopausal symptoms usually last for a few years during the perimenopausal and early postmenopausal period, typically resolving over a period of 5 to 10 years for most women, although some may experience symptoms for longer, even into their 60s.
Cost of Treatment (Initial)
Highly variable, ranging from minimal (lifestyle changes, over-the-counter supplements) to moderate (doctor visits, prescription medications like hormone replacement therapy or non-hormonal drugs), potentially several hundred euros for initial consultations and medication.
Cost of Treatment (Lifetime)
Can range from low (intermittent symptom management, supplements) to significant (long-term hormone replacement therapy, regular specialist visits, managing associated conditions like osteoporosis), potentially thousands of euros over several years.
Mortality Rate
Extremely low directly from menopausal symptoms. However, the long-term decline in estrogen contributes to increased risks of cardiovascular disease and osteoporosis in the postmenopausal period, which can indirectly affect longevity.
Risk of Secondary Damages
High. Common secondary damages include increased risk of osteoporosis, cardiovascular disease, urogenital atrophy (vaginal dryness, urinary issues), sleep disturbances, mood disorders (anxiety, depression), and reduced quality of life due to persistent symptoms.
Probability of Full Recovery
High, in terms of symptom resolution. Menopause is a natural physiological transition, not an illness with a 'recovery' in the traditional sense. Most women will see their menopausal symptoms resolve or significantly diminish over several years, although some changes like vaginal atrophy or bone density loss may persist or worsen without intervention.
Underlying Disease Risk
Low, as menopausal symptoms are part of a natural physiological process. However, other conditions such as thyroid disorders, depression, or certain gynecological issues can mimic or exacerbate menopausal symptoms, requiring differential diagnosis. Menopause itself increases risk for certain long-term conditions like osteoporosis and cardiovascular disease.